95% Effective with a Warning

Pfizer and partner BioNTech’s experimental injection meets expectations on agency guidance and is enough to initiate an agency review, according to staff of the U.S. Food and Drug Administration.

FDA/Pfizer Briefing Materials

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: